Incremental Costs for Psoriasis and Psoriatic Arthritis in a Population-based Cohort in Southern Sweden: Is It All Psoriasis-attributable Morbidity?

Research output: Contribution to journalArticlepeer-review

Abstract

To estimate incremental costs for patients with psoriasis/psoriatic arthritis (PsO/PsA) compared to population-based referents free from PsO/PsA and estimate costs attributable specifically to PsO/PsA.
Original languageEnglish
Pages (from-to)640-647
JournalJournal of Rheumatology
Volume43
Issue number3
Early online date2016 Jan 15
DOIs
Publication statusPublished - 2016

Subject classification (UKÄ)

  • Health Care Service and Management, Health Policy and Services and Health Economy

Cite this